Different reports have indicated that Th17 cells have a relevant role in the pathogenesis of RA and suggest that these lymphocytes and the cytokines released by them (mainly IL-17A) are a plausible therapeutic target in this and other immune-mediated inflammatory diseases [6, 17]. The gene discussed is IL17A; the disease is rheumatoid arthritis.